ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years
Yi Zhang
Matched on ORCID iD 0000-0003-3641-0629; OpenAlex author ID A5100388327. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Radiotherapy combined with serplulimab, and chemotherapy as first-line treatment for metastatic pancreatic adenocarcinoma: a multicenter, single-arm, phase II … Co-author DOI 10.1158/1078-0432.ccr-26-1824↗
- Umbilical neoplasm as the first sign of pancreatic adenocarcinoma. Last author DOI 10.15537/1658-3175.6021↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zixing Huang · 1 shared paper, 2026 · strength 0.19
- Chen Chang · 1 shared paper, 2026 · strength 0.19
- Junjie Xiong · 1 shared paper, 2026 · strength 0.19
- Yi Cheng · 1 shared paper, 2026 · strength 0.19
- Ke Cheng · 1 shared paper, 2026 · strength 0.19
- Dan Cao · 1 shared paper, 2026 · strength 0.19
- Xiaorui Zhu · 1 shared paper, 2026 · strength 0.19
- Qingqing Leng · 1 shared paper, 2026 · strength 0.19
- Wanting Hou · 1 shared paper, 2026 · strength 0.19
- Chenyan Zhang · 1 shared paper, 2026 · strength 0.19
- Bole Tian · 1 shared paper, 2026 · strength 0.19
- Bole Tian · 1 shared paper, 2014 · strength 0.06
- Anping Su · 1 shared paper, 2014 · strength 0.06
- Min Yang · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.